News
Daiichi Sankyo struck gold with ‘ADC’ cancer drugs. Its new CEO has to figure out what’s next.
Enhertu, Datroway and other antibody-drug conjugates developed by Daiichi Sankyo have made the company a leader in a ...
Breast cancer study results impressed at this year’s meeting, but raised new questions. Doctors also wrestled with how best ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results